- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT03191591
The First 1,000 Days Program: Maternal-Child Obesity Prevention in Early Life
The First 1000 Days (conception to age 2) is a crucial period for the development and prevention of obesity and its adverse consequences in mother-child pairs and their families. The overall aim of the First 1000 Days program is to work across early-life systems to prevent obesity, promote healthy routines and behaviors, address social determinants of health, and reduce health disparities among vulnerable children and families at community health centers in the Boston, MA area.
The study aims to simultaneously implement and evaluate an obesity prevention program across early life systems to reduce the prevalence of obesity risk factors within racial/ethnic minority families, close the gap in maternal-child health disparities, and assess and address social determinants of health.
Visão geral do estudo
Status
Condições
Intervenção / Tratamento
Tipo de estudo
Inscrição (Antecipado)
Estágio
- Não aplicável
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
- Filho
- Adulto
- Adulto mais velho
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria:
- All pregnant women receiving prenatal care at select community health centers in the Boston, MA area
- All families of children aged 0-2 years receiving pediatric care at select community health centers in the Boston, MA area
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Prevenção
- Alocação: N / D
- Modelo Intervencional: Atribuição de grupo único
- Mascaramento: Nenhum (rótulo aberto)
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
---|---|
Experimental: First 1,000 Days Program
|
Program components will include 1) Enhancements to and improved use of electronic health records to improve the quality of preventive services and screening for social determinants of health; 2) Staff and provider training; 3) Consistent behavior change messaging; 4) Patient education via print materials, text messaging and short videos; and 5) Strengthening the integration of clinical and public health services to support behavior change and address social determinants of health.
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
---|---|---|
Maternal Gestational Weight Gain
Prazo: First prenatal care visit to 36 weeks gestation
|
Weight gained during pregnancy
|
First prenatal care visit to 36 weeks gestation
|
Infant Weight-for-Length Z-Score
Prazo: Child age 6 months
|
Age- and sex-specific weight-for-length z-score
|
Child age 6 months
|
Infant Weight-for-Length Z-score
Prazo: Child age 12 months
|
Age- and sex-specific weight-for-length z-score
|
Child age 12 months
|
Infant Weight-for-Length Z-Score
Prazo: Child age 24 months
|
Age- and sex-specific weight-for-length z-score
|
Child age 24 months
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
---|---|---|
Change from 1st trimester maternal diet to 3rd trimester
Prazo: An average of 18 weeks (1st trimester to 3rd trimester)
|
Average weekly intake
|
An average of 18 weeks (1st trimester to 3rd trimester)
|
Change from 1st trimester maternal physical activity to 3rd trimester
Prazo: An average of 18 weeks (1st trimester to 3rd trimester)
|
Days per week physically active for at least 30 minutes per day
|
An average of 18 weeks (1st trimester to 3rd trimester)
|
Change from 1st trimester maternal sleep duration to 3rd trimester
Prazo: An average of 18 weeks (1st trimester to 3rd trimester)
|
Average hours per day
|
An average of 18 weeks (1st trimester to 3rd trimester)
|
Change from 1st trimester maternal sedentary time to 3rd trimester
Prazo: An average of 18 weeks (1st trimester to 3rd trimester)
|
Hours per day of screentime
|
An average of 18 weeks (1st trimester to 3rd trimester)
|
Change from 1st trimester depression to 3rd trimester
Prazo: An average of 18 weeks (1st trimester to 3rd trimester)
|
Edinburgh Postnatal Depression Scale
|
An average of 18 weeks (1st trimester to 3rd trimester)
|
Change from 1st trimester maternal food insecurity to 3rd trimester
Prazo: An average of 18 weeks (1st trimester to 3rd trimester)
|
2-question validated scale
|
An average of 18 weeks (1st trimester to 3rd trimester)
|
Change from 1st trimester maternal housing insecurity to 3rd trimester
Prazo: An average of 18 weeks (1st trimester to 3rd trimester)
|
2-question validated scale
|
An average of 18 weeks (1st trimester to 3rd trimester)
|
Change from 1st trimester pregnancy-related anxiety to 3rd trimester
Prazo: An average of 18 weeks (1st trimester to 3rd trimester)
|
5-question validated scale
|
An average of 18 weeks (1st trimester to 3rd trimester)
|
Change from 1st trimester enrollment in food assistance programs to 3rd trimester
Prazo: An average of 18 weeks (1st trimester to 3rd trimester)
|
Yes/No response options for program enrollment in WIC and SNAP
|
An average of 18 weeks (1st trimester to 3rd trimester)
|
Colaboradores e Investigadores
Publicações e links úteis
Publicações Gerais
- Blake-Lamb T, Boudreau AA, Matathia S, Perkins ME, Roche B, Cheng ER, Kotelchuck M, Shtasel D, Taveras EM. Association of the First 1,000 Days Systems-Change Intervention on Maternal Gestational Weight Gain. Obstet Gynecol. 2020 May;135(5):1047-1057. doi: 10.1097/AOG.0000000000003752.
- Simione M, Moreno-Galarraga L, Perkins M, Price SN, Luo M, Kotelchuck M, Blake-Lamb TL, Taveras EM. Effects of the First 1000 Days Program, a systems-change intervention, on obesity risk factors during pregnancy. BMC Pregnancy Childbirth. 2021 Oct 27;21(1):729. doi: 10.1186/s12884-021-04210-9.
- Taveras EM, Perkins ME, Boudreau AA, Blake-Lamb T, Matathia S, Kotelchuck M, Luo M, Price SN, Roche B, Cheng ER. Twelve-Month Outcomes of the First 1000 Days Program on Infant Weight Status. Pediatrics. 2021 Aug;148(2). pii: e2020046706. doi: 10.1542/peds.2020-046706.
- Cruz-Bendezu AM, Lovell GV, Roche B, Perkins M, Blake-Lamb TL, Taveras EM, Simione M. Psychosocial status and prenatal care of unintended pregnancies among low-income women. BMC Pregnancy Childbirth. 2020 Oct 12;20(1):615. doi: 10.1186/s12884-020-03302-2.
- Blake-Lamb T, Boudreau AA, Matathia S, Tiburcio E, Perkins ME, Roche B, Kotelchuck M, Shtasel D, Price SN, Taveras EM. Strengthening integration of clinical and public health systems to prevent maternal-child obesity in the First 1,000Days: A Collective Impact approach. Contemp Clin Trials. 2018 Feb;65:46-52. doi: 10.1016/j.cct.2017.12.001. Epub 2017 Dec 7.
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Real)
Conclusão do estudo (Real)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- 2016P000801
- 1K24DK105989 (Concessão/Contrato do NIH dos EUA)
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
produto fabricado e exportado dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .
Ensaios clínicos em First 1,000 Days Program Site
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)ConcluídoMucosite | Neoplasia Maligna de Cabeça e Pescoço | Transtorno induzido por radiaçãoEstados Unidos